BRO vs PPCB · P/E 30, rev $4.80B vs P/E 0.0, $3.9M cap
Brown & Brown Inc (BRO) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
PPCB does not have a complete income-statement cache yet.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the BRO and PPCB stock pages for the full models.
Not investment advice.